197 related articles for article (PubMed ID: 8781889)
1. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Barry AL; Brown SD; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
[TBL] [Abstract][Full Text] [Related]
2. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
Thornsberry C; Burton PH; Vanderhoof BH
Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
4. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
[TBL] [Abstract][Full Text] [Related]
6. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
Williams-Bouyer N; Hernandez A; Reisner BS
J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
Skulnick M; Small GW; Lo P; Patel MP; Porter CR; Low DE; Matsumura S; Mazzulli T
J Clin Microbiol; 1995 Sep; 33(9):2334-7. PubMed ID: 7494023
[TBL] [Abstract][Full Text] [Related]
8. Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.
Barry AL; Fuchs PC
J Clin Microbiol; 1996 Oct; 34(10):2609-12. PubMed ID: 8880533
[TBL] [Abstract][Full Text] [Related]
9. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
Friedland IR; Shelton S; McCracken GH
J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
[TBL] [Abstract][Full Text] [Related]
10. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
[TBL] [Abstract][Full Text] [Related]
11. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
Bell SM; Gatus BJ; Pham JN
Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
[No Abstract] [Full Text] [Related]
12. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
13. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
Haas DW; Stratton CW; Griffin JP; Weeks L; Alls SC
Clin Infect Dis; 1995 Mar; 20(3):671-6. PubMed ID: 7756494
[TBL] [Abstract][Full Text] [Related]
14. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Goldstein FW
Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.
Bosley GS; Elliott JA; Oxtoby MJ; Facklam RR
Diagn Microbiol Infect Dis; 1987 May; 7(1):21-7. PubMed ID: 3691031
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
Cormican MG; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
[TBL] [Abstract][Full Text] [Related]
17. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
[TBL] [Abstract][Full Text] [Related]
18. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
Johnson DM; Doern GV; Haugen TA; Hindler J; Washington JA; Jones RN
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):137-41. PubMed ID: 8902410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
